US EditionHow Trump's Online Drugstore May Affect Your Drug Costs
TrumpRx offers discounts on select Pfizer drugs and includes a $70 billion investment in U.S. drug manufacturing, aiming to bypass insurance for direct consumer access.
- On Tuesday, President Donald Trump and Pfizer chairman and CEO Albert Bourla announced TrumpRx and a three-year tariff reprieve, with TrumpRx.gov set to launch next year to connect consumers with manufacturers.
- Bypassing insurance, TrumpRx aims to direct-sell medicines, with Pfizer offering discounts and starting U.S. production during the three-year grace period.
- Pfizer said it will make six products available through TrumpRx.gov next year, including Duavee, Eucrisa, and Toviaz, with Xeljanz at a 40% discount and Zavzpret at 50%.
- The Wall Street Journal editorial board sharply criticized TrumpRx as bypassing insurance and a political stunt, while a New York legal expert warned of privacy risks and analysts noted limited impact since out-of-pocket drug spending is only 1%.
- Direct-Sales programs could shift pharmaceutical supply chain models by bringing discounts closer to patients, while Pfizer’s $70 billion investment in coming years builds on more than $83 billion from 2018 to 2024.
11 Articles
11 Articles
US President Trump announced a deal with Pfizer that offers discounts on medications of 50% to 100%, "and in some cases, even more." I don't think Pfizer will give away any money. The deal is good for poor Americans, but ultimately doesn't amount to much for Pfizer. In short: a smart move by Pfizer.
'Political extortion': WSJ delivers tongue-lashing over TrumpRx
President Donald Trump got a tongue-lashing from the conservative-leaning Wall Street Journal editorial board on Wednesday over his announcement of "TrumpRx" — a website intended to bypass insurance and sell prescription drugs directly to consumers at discounted prices.Already, some experts have rai...
How Trump's Online Drugstore May Affect Your Drug Costs
President Donald Trump and top health officials heralded their drug pricing deal with Pfizer on Tuesday as a breakthrough that would save money for American patients struggling with prescription drug costs.
Times of India
The Economic TimesTrumpRx website 2025: direct-to-consumer prescription drug platform and Pfizer discount deal explained
President Donald Trump announced TrumpRx, a government-operated website launching early 2026 for discounted prescription drugs. Pfizer agreed to offer medications at 50-85% discounts through direct-to-consumer sales. The site redirects consumers to manufacturers' purchasing channels, not selling drugs directly
The United States will launch a website called TrumpRx.gov, which will allow people to get cheaper drugs. President Donald Trump announced this on Tuesday. On this occasion, he announced an agreement with the pharmaceutical company Pfizer, thanks to which he expects the prices of some drugs to be reduced by up to 50 percent, according to American media. Trump has long pointed out that drugs in the US are too expensive.
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
